Ticker Details
Dyne Therapeutics, Inc.
IPO Date:	September 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.87B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 3.57%
Avg Daily Range (30 D):	$0.71 | 2.90%
Avg Daily Range (90 D):	$0.60 | 2.94%

Institutional Daily Volume
Avg Daily Volume:	.92M
Avg Daily Volume (30 D):	1.85M
Avg Daily Volume (90 D):	1.61M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	2,741
Avg Institutional Trade:	$2.6M
Avg Institutional Trade (30 D):	$3.48M
Avg Institutional Trade (90 D):	$3.27M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.72M
Avg Closing Trade (30 D):	$9.91M
Avg Closing Trade (90 D):	$7.53M
Avg Closing Volume:	246.73K

News

Jul 22, 2026 @ 2:46 AM Dyne Therapeutics Announces Pricing of Upsized $37... Source: Na

Jul 21, 2026 @ 8:46 PM Dyne Therapeutics Announces Proposed Public Offeri... Source: Na

Jun 26, 2026 @ 3:05 PM Dyne Therapeutics vs. Viking Therapeutics: Which H... Source: Sara Appino

May 30, 2026 @ 4:28 PM Dyne Stock Is Up 56%. Here's What a $14 Million St... Source: Jonathan Ponciano

May 26, 2026 @ 5:00 PM Duchenne Muscular Dystrophy Clinical Trial Pipelin... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.3	$-1.08	$-.73
Diluted EPS	$-3.3	$-1.08	$-.73
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-519.41M	$-178.56M	$-120.85M
Operating Income / Loss	$-536.96M	$-181.66M	$-125.28M
Cost of Revenue
Net Cash Flow	$191.48M	$-76.97M	$-140.25M
PE Ratio